| Makale Türü |
|
||
| Dergi Adı | International Journal of Ophthalmology (Q3) | ||
| Dergi ISSN | 2222-3959 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | Türkçe | Basım Tarihi | 04-2025 |
| Cilt / Sayı / Sayfa | 18 / 4 / 637–641 | DOI | 10.18240/ijo.2025.04.09 |
| Makale Linki | https://doi.org/10.18240/ijo.2025.04.09 | ||
| UAK Araştırma Alanları |
Göz Hastalıkları
|
||
| Özet |
| AIM To investigate the optimal anti-vascular endothelial growth factor (VEGF) treatment time in patients with diabetic macular edema (DME) scheduled for cataract surgery. METHODS The study was designed to include 4 groups. Twenty-six eyes of 26 patients with diabetes but no retinopathy (DR; group 1), 17 eyes of 17 patients with DR but no DME (group 2), and 19 eyes of 19 patients with DME who received anti-VEGF therapy concurrently with cataract surgery (group 3), and 21 eyes of 21 patients who received anti-VEGF therapy for DME 1wk before cataract surgery (group 4). The patients' best corrected visual acuity, intraocular pressure, central and mean macular thickness (CMT and MMT) values were noted on the day of surgery, postoperative day 1, week 1, and month 1. RESULTS There was a significant increase of CMT after cataract surgery in groups 1, 2, and 3 (P<0.001, P=0.044, and P=0.034 … |
| Anahtar Kelimeler |
| cataract surgery | diabetic macular edema | timing of anti-vascular endothelial growth factor therapy |
| Dergi Adı | International Journal of Ophthalmology |
| Yayıncı | International Journal of Ophthalmology (c/o Editorial Office) |
| Açık Erişim | Evet |
| ISSN | 2222-3959 |
| E-ISSN | 2227-4898 |
| CiteScore | 2,8 |
| SJR | 0,544 |
| SNIP | 0,730 |